# SWOG Network Group Operations Center of the NCTN

> **NIH NIH U10** · OREGON HEALTH & SCIENCE UNIVERSITY · 2024 · $849,488

## Abstract

SWOG's overarching goal is to conduct high-impact cancer trials with results meaningful to our investigators and
patients. In a recent analysis, SWOG investigators examined how our treatment trials have benefited patients
with cancer in the general population over the course of its 60-year history (Unger, JAMA Oncol 2017). Three
and one-third million life-years were gained in the population of US patients with cancer through 2015, at an
investment dollar cost on the part of the NCI of $125 per life-year gained. This clearly illustrates how the NCI's
investment in its cancer cooperative group research program has provided exceptional value and benefit to the
American public. We will continue to develop and conduct trials aimed at making a significant, cost-effective
difference for those affected by cancer.

## Key facts

- **NIH application ID:** 10833101
- **Project number:** 5U10CA180888-11
- **Recipient organization:** OREGON HEALTH & SCIENCE UNIVERSITY
- **Principal Investigator:** CHARLES D. BLANKE
- **Activity code:** U10 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $849,488
- **Award type:** 5
- **Project period:** 2014-04-17 → 2026-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10833101

## Citation

> US National Institutes of Health, RePORTER application 10833101, SWOG Network Group Operations Center of the NCTN (5U10CA180888-11). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10833101. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*